Physician Assistant · Lancaster, PA
NPI
1235878927
Since 2022
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1808 Colonial Village Ln Ste 103
Lancaster, PA, 17601
Phone (717) 391-0172
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$661K
3,638 prescriptions
Company payments, 2025
$2,576
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Vincent C Dubesky prescribed most often to Medicare patients was Trazodone Hcl, with 218 prescriptions and refills. In total Vincent C Dubesky wrote 3,638 Medicare prescriptions that cost $661K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Trazodone Hcl Generic | 218 | 275 | 32 | $1,336 |
| Sertraline Hcl Generic | 174 | 219 | 25 | $1,311 |
| Olanzapine Generic | 162 | 181 | 21 | $3,332 |
| Aripiprazole Generic | 157 | 189 | 22 | $7,611 |
| Escitalopram Oxalate Generic | 153 | 172 | 23 | $1,061 |
| Clozapine Generic | 141 | 141 | Under 11 | $3,759 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 137 | 172 | 14 | $3,318 |
| Bupropion Xl Bupropion Hcl | 114 | 176 | 21 | $2,578 |
| Buspirone Hcl Generic | 110 | 154 | 18 | $1,238 |
| Lamotrigine Generic | 109 | 136 | 18 | $533 |
| Quetiapine Fumarate Generic | 104 | 138 | 14 | $1,406 |
| Vraylar Cariprazine Hcl | 99 | 99 | 12 | $129K |
| Divalproex Sodium Er Divalproex Sodium | 92 | 104 | 15 | $2,986 |
| Duloxetine Hcl Generic | 91 | 139 | 18 | $1,375 |
| Clonidine Hcl Generic | 83 | 102 | 12 | $257 |
Brand drugs: 326 claims; generic drugs: 3,312 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincent C Dubesky $2,576 ($2,576 in general payments such as food, travel and fees) from 14 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $486.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $486 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 17 | $429 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $382 |
| Neurocrine BioSciences, Inc. NBIX | 11 | $322 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $229 |
| Alkermes, Inc. ALKS | 6 | $209 |
| Abbvie Inc. ABBV | 15 | $141 |
| Axsome Therapeutics, Inc. AXSM | 6 | $133 |
| Lundbeck LLC | 3 | $76.66 |
| Supernus Pharmaceuticals, Inc. SUPN | 3 | $52.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.